Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5428]
News [12614]
Articles [173]
Editorials [5]
Conferences [246]
elearning [17]
Comment: Genetic testing of early breast tumours could allow patients to go...
Dr Harold Burstein & Prof Richard Schilsky
Comment: Genetic testing of early breast tumours could allow patients to go without chemo ( Dr Harold Burstein & Prof Richard Schilsky )
3 Jun 2018
Comment: Paediatric rhabdomyosarcoma survival extended with maintenance...
Prof Richard Schilsky & Dr Gianni Bisogno
Comment: Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy ( Prof Richard Schilsky & Dr Gianni Bisogno )
3 Jun 2018
Comment: Kidney surgery may be unneeded in many intermediate-risk patients
Dr Sumanta Pal & Prof Richard Schilsky
Comment: Kidney surgery may be unneeded in many intermediate-risk patients ( Dr Sumanta Pal & Prof Richard Schilsky )
3 Jun 2018
Genetic testing of early breast tumours could allow patients to go without chemo
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
Genetic testing of early breast tumours could allow patients to go without chemo ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
3 Jun 2018
PD-1 immunotherapy better than chemo alone as first line lung cancer treatment
Dr Gilberto Lopes - Oncoclinicas do Brasil, São Paulo, Brazil
PD-1 immunotherapy better than chemo alone as first line lung cancer treatment ( Dr Gilberto Lopes - Oncoclinicas do Brasil, São Paulo, Brazil )
3 Jun 2018
Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy ( Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy )
3 Jun 2018
Kidney surgery may be unneeded in many intermediate-risk patients
Prof Arnaud Mejean - Paris Descartes University, Paris, France
Kidney surgery may be unneeded in many intermediate-risk patients ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )
3 Jun 2018
ASCO 2018: Latest in bladder cancer treatments
Prof Thomas Powles & Prof Shahrokh Shariat
ASCO 2018: Latest in bladder cancer treatments ( Prof Thomas Powles & Prof Shahrokh Shariat )
3 Jun 2018
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer
Prof Kurt Miller and Prof Bertrand Tombal
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer ( Prof Kurt Miller and Prof Bertrand Tombal )
2 Jun 2018
A multi-histology basket trial of ado-trastuzumab emtansine in patients with...
Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA
A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers ( Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA )
2 Jun 2018
Zoptarelin no better than doxarubicin for second-line advanced endometrial...
Dr David Miller - The University of Texas Southwestern Medical Center
Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer ( Dr David Miller - The University of Texas Southwestern Medical Center )
2 Jun 2018
Improving global breast cancer care
Prof Carlos Barrios - Pontifica Universidade Catolica de Rio Grande do Sul...
Improving global breast cancer care ( Prof Carlos Barrios - Pontifica Universidade Catolica de Rio Grande do Sul, Brazil )
2 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation